Endo, Y., Sakura, Y., Kaneko, G., Hayakawa, N., Ikarashi, D., Yamashita, R., Shirotake, S., Obara, W., Kondo, Y., Kikuchi, E. (2026). Early relative dose intensity to predict survival outcomes in patients treated with enfortumab vedotin for metastatic urothelial carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.683